Insiders, Restructuring, Workforce

AstraZeneca CEO Soriot is overseeing a top exec team overhaul in move to integrate MedImmune in a sweeping restructuring

AstraZeneca CEO Pascal Soriot poses for a photograph following a television interview late last year Bloomberg


EXCLUSIVE — The ongoing R&D reorganization at AstraZeneca is claiming a group of senior executives in the company’s US R&D organization as AstraZeneca absorbs its big subsidiary MedImmune into a newly revamped global organization.

The pharma giant is handling fresh exits from Bahija Jallal’s senior leadership team at AstraZeneca’s MedImmune subsidiary — up until her departure a few weeks ago to take the CEO’s job at Immunocore in the UK, sources familiar with the latest moves tell me. More departures are expected. And current MedImmune execs have been spreading the word that the subsidiary will soon end its 11-year run as a separate organization as the company reorganizes under two previously announced main R&D banners, splitting MedImmune’s large molecule work between two disease-specific organizations.

The reorganization has sparked intense rumors about which research groups will come out on top and which will be relegated to the sidelines.

Endpoints Insider

Endpoints Enterprise

Unlock this article along with other benefits by subscribing to one of our paid plans.
Already a subscriber? Log in now
← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 47,200+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 47,200+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT
Director of Operations
Atlas Venture Cambridge, MA

Visit Endpoints Careers ->